Related Experiment Video
Updated: Oct 17, 2025

Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
Mechanisms of Connexin Regulating Peptides
D Ryan King1, Meghan W Sedovy1,2, Xinyan Leng1
1Fralin Biomedical Research Institute at Virginia Tech Carilion School of Medicine, Virginia Tech, Roanoke, VA 24016, USA.
Abstract:
Gap junctions (GJ) and connexins play integral roles in cellular physiology and have been found to be involved in multiple pathophysiological states from cancer to cardiovascular disease. Studies over the last 60 years have demonstrated the utility of altering GJ signaling pathways in experimental models, which has led to them being attractive targets for therapeutic intervention. A number of different mechanisms have been proposed to regulate GJ signaling, including channel blocking, enhancing channel open state, and disrupting protein-protein interactions. The primary mechanism for this has been through the design of numerous peptides as therapeutics, that are either currently in early development or are in various stages of clinical trials. Despite over 25 years of research into connexin targeting peptides, the overall mechanisms of action are still poorly understood. In this overview, we discuss published connexin targeting peptides, their reported mechanisms of action, and the potential for these molecules in the treatment of disease.
Insights
Gap junctions (GJ) and connexins are crucial for cell function and disease. This review examines connexin-targeting peptides, exploring their therapeutic potential and mechanisms of action for various diseases.
Area of Science:
- Cellular physiology and molecular biology
- Pharmacology and drug discovery
- Pathophysiology of diseases
Background:
- Gap junctions (GJ) and connexins are vital for cellular communication and implicated in diseases like cancer and cardiovascular conditions.
- Altering GJ signaling pathways shows therapeutic potential, making them attractive drug targets.
- Peptides are a primary strategy for modulating GJ signaling, with many in development or clinical trials.
Purpose of the Study:
- To review published connexin-targeting peptides.
- To elucidate their reported mechanisms of action.
- To assess their potential in disease treatment.
Main Methods:
- Literature review of published research on connexin-targeting peptides.
- Analysis of proposed and reported mechanisms of action.
- Evaluation of therapeutic potential based on existing studies.
Main Results:
- Numerous peptides targeting connexins have been developed.
- Various mechanisms, including channel blocking and protein interaction disruption, are proposed.
- Despite extensive research, precise mechanisms of action remain poorly understood.
Conclusions:
- Connexin-targeting peptides represent a promising therapeutic avenue.
- Further research is needed to fully understand their mechanisms of action.
- These peptides hold potential for treating a range of diseases.
Related Concept Videos
Gap Junctions
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

